EORTC on the future of cancer research at ECCO 2017
19 Jan 2017
World experts to discuss future methods in cancer research at EORTC ECCO workshop
Our workshop on the Future of Cancer Clinical Research & Therapy will bring together world experts Elizabeth Eisenhauer (Queen’s University, Canada), Stefan Sleijfer (Erasmus University, Netherlands) and Jorge Camarero (European Medicines Agency), to discuss “The regulatory and methodological dimensions of long term efficacy: PFS2 and looking beyond the first progression”.
This discussion will be followed by a session on “Registries and the external validity of clinical trials” with Gemma Gatta (Istituto Nazionale Tumori di Milano), Sabine Siesling (University of Twente, Netherlands) and Harlinde De Schutter (Belgian Cancer Registry).
Poster sessions
In addition, EORTC will be presenting two posters at the European Cancer Congress (ECCO 2017) in Amsterdam (January 27-30, 2017).
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials – SISAQOL consortium (Abstract 1333)
Session 226: Poster in the Spotlight II; Saturday 28.01.2017 – 4:00 PM – 5:00 PM
Location: Poster Area, Hall 1
Author: SISAQOL consortium
Update of the international prognostic classification for first line metastatic germ-cell cancers. An international initiative (Abstract 2197)
Session 255: Poster in the Spotlight IV; Sunday 29.01.2017 – 4:00 PM – 4:50 PM
Location: Poster Area, Hall 1
Author: L. Collette
Oral Presentations
Innovative methodology to optimise translation of trial outcome to real-world patients
Changing Practice Session: The Value of Cancer Registries; Sunday 29.01.2017 – 11:30 AM
Location: Room Zur Hausen
Speaker: L. Liu
Incorporating real-life data into drug development: towards more pragmatic trials
Changing Practice Session: External Validity of Clinical Trials; Monday 30.01.2017 – 10:35 AM
Location: Room Folkman
Speaker: M. Mauer
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023